Article Details
Retrieved on: 2024-11-15 01:33:16
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Alliance Global Partners lowered the firm's price target on PDS Biotechnology (PDSB) to $4.50 from $7 and keeps a Buy rating on the shares...
Article found on: markets.businessinsider.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here